Inflammation, cancer, and bone loss

被引:28
作者
Abu-Amer, Yousef [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
关键词
NF-KAPPA-B; BINDING DOMAIN PEPTIDE; TUMOR-NECROSIS-FACTOR; KINASE IKK INHIBITOR; PROSTATE-CANCER; OSTEOCLAST DIFFERENTIATION; BLOCKS OSTEOCLASTOGENESIS; SELECTIVE-INHIBITION; CUTTING EDGE; NEMO;
D O I
10.1016/j.coph.2009.06.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Skeletal distortions impose grave health disparities with potentially devastating consequences, including bone pain, immobility, and morbidity. Bone erosion is chiefly caused by hyperactive osteoclasts summoned to bone in response to circulating factors produced by tumor and inflammatory cells. Intense research in the past two decades has identified crucial elements and intricate circulatory systems that maintain and exacerbate inflammatory osteolysis. This progress led to better understanding of the mechanisms underlying this response and to developing advanced therapeutic interventions. Nevertheless, the multifactorial causes of inflammatory osteolysis continue to impose a great challenge for these therapies. This article provides an overview of some of the prominent facets contributing to this process.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 54 条
[1]   The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO [J].
Abbott, DW ;
Wilkins, A ;
Asara, JM ;
Cantley, LC .
CURRENT BIOLOGY, 2004, 14 (24) :2217-2227
[2]   Role of the NF-κB axis in immune modulation of osteoclasts and bone loss [J].
Abu-Amer, Yousef ;
Darwech, Isra ;
Otero, Jesse .
AUTOIMMUNITY, 2008, 41 (03) :204-211
[3]  
Abu-Amer Yousef, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P347, DOI 10.2174/1568008054863808
[4]   Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice [J].
Attar, RM ;
Caamano, J ;
Carrasco, D ;
Iotsova, V ;
Ishikawa, H ;
Ryseck, RP ;
Weih, F ;
Bravo, R .
SEMINARS IN CANCER BIOLOGY, 1997, 8 (02) :93-101
[5]   Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential [J].
Bogoyevitch, MA ;
Boehm, I ;
Oakley, A ;
Ketteman, AJ ;
Barr, RK .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2) :89-101
[6]   Inflammatory diseases: Is ubiquitinated NEMO at the hub? [J].
Burns, KA ;
Martinon, F .
CURRENT BIOLOGY, 2004, 14 (24) :R1040-R1042
[7]   Osteoclast differentiation is impaired in the absence of inhibitor of κB kinase α [J].
Chaisson, ML ;
Branstetter, DG ;
Derry, JM ;
Armstrong, AP ;
Tometsko, ME ;
Takeda, K ;
Akira, S ;
Dougall, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) :54841-54848
[8]   Breast cancer bone metastasis and current small therapeutics [J].
Cicek, Muzaffer ;
Oursler, Merry Jo .
CANCER AND METASTASIS REVIEWS, 2006, 25 (04) :635-644
[9]   NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis [J].
Clohisy, JC ;
Hirayama, T ;
Frazier, E ;
Han, SK ;
Abu-Amer, Y .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2004, 22 (01) :13-20
[10]   Direct inhibition of NF-κB blocks bone erosion associated with inflammatory arthritis [J].
Clohisy, JC ;
Roy, BC ;
Biondo, C ;
Frazier, E ;
Willis, D ;
Teitelbaum, SL ;
Abu-Amer, Y .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :5547-5553